🎗️ OncologyCapsule
Rezlidhia
Olutasidenib
IDH1 inhibitor for relapsed or refractory acute myeloid leukemia with IDH1 mutation.
Form
Capsule
Uses
1
Side effects
5
Category
Oncology
01
What is Rezlidhia used for?
- Relapsed/refractory IDH1-mutated AML
02
Olutasidenib side effects
The following side effects have been reported for Olutasidenib. Their order does not indicate how often an effect occurs.
Nausea
Fatigue
Arthralgia
Leukocytosis
Elevated liver enzymes
03
Olutasidenib warnings & precautions
- Differentiation syndrome. Monitor and treat promptly
- QTc prolongation risk
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Rezlidhia in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.